These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21936612)

  • 21. Quantification of apoptotic phenomenon on endometrial biopsies in postmenopausal patients under hormonal replacement therapy (HRT).
    Terzea D; Iosif C; Vasilescu F; Andrei F; Dobrea C; Nicolae A; Georgescu A; Mircea F; Ceauşu M; Vişan A; Mihai M; Ardeleanu C
    Rom J Morphol Embryol; 2007; 48(2):107-11. PubMed ID: 17641796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International Conference on Harmonisation; guidance on Addendum to E2C Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Feb; 69(24):5551-2. PubMed ID: 14968802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estradiol-induced hyperplasia in endometrial biopsies from women on hormone replacement therapy.
    Wright TC; Holinka CF; Ferenczy A; Gatsonis CA; Mutter GL; Nicosia S; Richart RM
    Am J Surg Pathol; 2002 Oct; 26(10):1269-75. PubMed ID: 12360041
    [No Abstract]   [Full Text] [Related]  

  • 24. Unopposed estradiol therapy in postmenopausal women: results from two randomized trials.
    Steiner AZ; Xiang M; Mack WJ; Shoupe D; Felix JC; Lobo RA; Hodis HN
    Obstet Gynecol; 2007 Mar; 109(3):581-7. PubMed ID: 17329508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Endometrial growth in continuous, estrogen substitution monotherapy with Estraderm TTS (0.05 mg/die) in 31 postmenopausal females].
    Meuwissen JH; van Langen H; Nielen M
    Geburtshilfe Frauenheilkd; 1992 Jun; 52(6):351-4. PubMed ID: 1634098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen.
    de Lignieres B
    J Reprod Med; 1999 Feb; 44(2 Suppl):191-6. PubMed ID: 11392031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy.
    Perez-Medina T; Bajo-Arenas J; Haya J; Sanfrutos L; Iniesta S; Bueno B; Castelo-Branco C
    Menopause; 2003; 10(6):534-7. PubMed ID: 14627862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. United States regulatory considerations for intrauterine progestins for hormone replacement therapy.
    Rarick L
    Contraception; 2007 Jun; 75(6 Suppl):S140-3. PubMed ID: 17531606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
    Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
    Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exogenous estrogens and endometrial carcinoma: review and comments for the clinician.
    Berger GS; Fowler WC
    J Reprod Med; 1977 Apr; 18(4):177-80. PubMed ID: 870690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical inquiries. What is the best diagnostic approach to postmenopausal vaginal bleeding in women taking hormone replacement therapy?
    Kerns JW; Mabry S; Lopez R
    J Fam Pract; 2001 Oct; 50(10):843-4. PubMed ID: 11674884
    [No Abstract]   [Full Text] [Related]  

  • 34. 4th Global CRO Council for Bioanalysis: coadministered drugs stability, EMA/US FDA guidelines, 483s and carryover.
    Lowes S; Jersey J; Shoup R; Garofolo F; Needham S; Couerbe P; Lansing T; Bhatti M; Sheldon C; Hayes R; Islam R; Lin Z; Garofolo W; Moussallie M; Teixeira Lde S; Rocha T; Jardieu P; Truog J; Lin J; Lundberg R; Breau A; Dilger C; Bouhajib M; Levesque A; Gagnon-Carignan S; Jenkins R; Nicholson R; Lin MH; Karnik S; DeMaio W; Smith K; Cojocaru L; Allen M; Fatmi S; Sayyarpour F; Malone M; Fang X
    Bioanalysis; 2012 Apr; 4(7):763-8. PubMed ID: 22512795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update and trends on pharmacokinetic studies in patients with impaired renal function: practical insight into application of the FDA and EMA guidelines.
    Paglialunga S; Offman E; Ichhpurani N; Marbury TC; Morimoto BH
    Expert Rev Clin Pharmacol; 2017 Mar; 10(3):273-283. PubMed ID: 27998190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OARSI Clinical Trials Recommendations: An abbreviated regulatory guide to the clinical requirements for development of therapeutics in osteoarthritis.
    Simon LS
    Osteoarthritis Cartilage; 2015 May; 23(5):674-6. PubMed ID: 25952340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors.
    Linkov F; Edwards R; Balk J; Yurkovetsky Z; Stadterman B; Lokshin A; Taioli E
    Eur J Cancer; 2008 Aug; 44(12):1632-44. PubMed ID: 18514507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New US FDA draft guidance on bioanalytical method validation versus current FDA and EMA guidelines: chromatographic methods and ISR.
    Zimmer D
    Bioanalysis; 2014 Jan; 6(1):13-9. PubMed ID: 24256335
    [No Abstract]   [Full Text] [Related]  

  • 39. Do the EMA accelerated assessment procedure and the FDA priority review ensure a therapeutic added value? 2006-2015: a cohort study.
    Boucaud-Maitre D; Altman JJ
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1275-1281. PubMed ID: 27473682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recommendation for hormone replacement therapy in postmenopause].
    Fait T; Donát J; Jenícek J; Burdová M; Zahrádková J; Koliba P
    Ceska Gynekol; 2010 Apr; 75(2):109-10. PubMed ID: 20518263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.